This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
MOUSE ANTI HUMAN HIF2 ALPHA
catalog :
MCA5645GA
quantity :
0.1 mg
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
Hif2alpha237
reactivity :
human
application :
immunohistochemistry, immunohistochemistry - paraffin section
citations: 1
product information
Entity Category :
Antibodies
Product Code :
MCA5645GA
Description :
MOUSE ANTI HUMAN HIF2 ALPHA
Specificity :
HIF2 ALPHA
Target Species :
Human
Host :
Mouse
Format :
Purified
Isotypes :
IgG2b
Applications :
P*
Application Types :
Immunohistology - Paraffin
Clone :
Hif2alpha237
Quantity :
0.1 mg
Quantity Value :
0.1 mg
Quantity Type :
mg
GO Accessions :
GO:0001525, GO:0001666, GO:0003705, GO:0003713, GO:0004871, GO:0005667, GO:0008134, GO:0035035, GO:0045944, GO:0046982, GO:0048625
GO Terms :
activation of transcription from RNA polymerase II promoter, blood vessel formation from pre-existing blood vessels, GO:0005062, GO:0009369, GO:0009370, gp130, hematopoietin/interferon-class (D200-domain) cytokine receptor signal transducer activity, histone acetylase binding, positive regulation of transcription from Pol II promoter, quorum sensing response regulator activity, quorum sensing signal generator activity, response to hypoxic stress, response to lowered oxygen tension, stimulation of transcription from RNA polymerase II promoter, TF binding, transcription co-activator activity, up regulation of transcription from RNA polymerase II promoter, upregulation of transcription from RNA polymerase II promoter, up-regulation of transcription from RNA polymerase II promoter
Uniprot Accessions :
Q99814
Gene :
EPAS1
GeneID URL :
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=2034
Published Synonyms :
EPAS-1
EntityFormats :
Purified
UNSPSC :
41116161
Concentration :
IgG concentration 1.0 mg/ml
Product Form :
Purified IgG - liquid
PrimarySecondary :
Primary
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.
questions and comments